On September 12, 2018, the FDA announced “historic action,” issuing 1,300 enforcement actions against retailers for selling Juul and other e-cigarettes to minors. While robust enforcement is a critical element of the FDA’s response to the public health crisis caused by JUUL and other similar products, there is a lot of information about the FDA’s efforts that the agency did not highlight. We’ve combed through the FDA’s enforcement data to find out whether the FDA’s actions are proportionate to the public health threat posed by Juul. This 30-minute mini-webinar highlights our findings.
This webinar has already occurred. Please use the resources below:
Desmond Jenson, Senior Staff Attorney, Public Health Law Center
Natalie Hemmerich, Staff Attorney, Public Health Law Center
For current information, visit our E-Cigarettes page.